Clinical trial Recruiting at 1 site Interventional Ages 16 to 40

tDCS plus exercise to improve motor control after ACL reconstruction

Official title: Effects of Transcranial Direct Current Stimulation Over Motor Cortex During Recovery of ACL Patients

Run by Fundación Universidad Católica de Valencia San Vicente Mártir · NCT06818201 · Data updated 2026-11-12

This trial will test whether adding non-invasive brain stimulation (tDCS) to exercise-based rehab helps people aged 16–40 recovering from ACL reconstruction regain better muscle control and function.

Quick facts

Study typeInterventional
Ages16 Years to 40 Years
SexAll
Enrollment54 (estimated)
SponsorFundación Universidad Católica de Valencia San Vicente Mártir
Academic / other
Locations1 site (Valencia, Valencia)
StatusRecruiting
StartedNovember 28, 2025
Main results expectedDecember 27, 2027
Study endsDecember 27, 2027
Registry record updatedDecember 2, 2025
Trial IDNCT06818201 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people aged 16–40 with a complete ACL tear treated surgically who were moderately to highly active before injury (Tegner ≥4).

Probably not a fit

Patients with additional knee/leg injuries, neurological disorders, recent concussion, cranial metal implants, or those taking medications that affect brain activity are unlikely to be eligible or to benefit.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants who had a complete ACL tear treated with surgery will receive a rehabilitation program that pairs transcranial direct current stimulation (tDCS) targeting the motor cortex with exercise, compared with sham tDCS plus the same exercises. The protocol measures cortical reorganization and corticospinal activation alongside pain, psychosocial measures, and functional outcomes to see if neuromuscular control improves. Key eligibility includes age 16–40 and a Tegner activity level of 4 or higher, while exclusions include other lower-limb pathology, neurological disease, recent concussion, cranial metal, or medications that affect neuronal activity. The study aims to determine whether supraspinal modulation via tDCS can reduce arthrogenic muscle inhibition and enhance recovery after ACL reconstruction.

Why it matters

Potential benefit: If successful, combining tDCS with exercise rehab could speed recovery of muscle control and reduce the risk of re-injury after ACL reconstruction.

How similar studies have gone: Small trials and pilot studies combining tDCS with physical rehabilitation for motor recovery have shown some promising but inconsistent results, so the approach remains experimental.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis complete ACL tear through clinical evaluation and MRI imaging.
* Patients who have received surgical intervention.
* Aged between 16 and 40 years.
* Tegner activity level of 4 or higher.

Exclusion Criteria:

* Rupture, such as tendons, cartilage, bones, or ligaments.
* Absence of any pre-existing or current lower limb pathologies, such as open surgeries, knee arthroscopies, or femur/tibia fractures.
* Neuromuscular or metabolic diseases.
* Concussion within the past six months are not eligible.
* Cranial surgery or have intracranial metal clips are ineligible.
* Taking medications that affect neuronal activity.
* Neurological diseases or disorders are not eligible for participation.

Where it's running

  • Catholic Univerity of Valencia
    Valencia, Valencia, Spain
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.